Minimal residual disease–guided therapy in childhood acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Minimal residual disease–guided therapy in childhood acute lymphoblastic leukemia

Published:2017-04-06 Issue:14 Volume:129 Page:1913-1918
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Campana Dario¹,Pui Ching-Hon²³

Affiliation:

1. Department of Pediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore;

2. Departments of Oncology and Pathology, St. Jude Children’s Research Hospital, Memphis, TN; and

3. Department of Pediatrics, University of Tennessee Health Science Center, Memphis, TN

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/129/14/1913/1399944/blood725804.pdf

Reference44 articles.

1. Immunological monitoring of residual disease in treated thymic acute lymphoblastic leukaemia;Bradstock;Leuk Res,1981

2. Detection of minimal residual disease in acute leukemia: methodologic advances and clinical significance;Campana;Blood,1995

3. New markers for minimal residual disease detection in acute lymphoblastic leukemia;Coustan-Smith;Blood,2011

4. Standardized flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia;Theunissen;Blood,2017

5. Minimal residual disease monitoring in childhood acute lymphoblastic leukemia;Campana;Curr Opin Hematol,2012

Cited by 104 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Screening and interventional strategies for the late effects and toxicities of hematological malignancy treatments in pediatric survivors;Expert Review of Hematology;2024-06-25

2. Flow Cytometry-Based Detection of Minimal/Measurable Residual Disease Predicts Survival Outcomes in Pediatrics, Adolescents, and Young Adults With T-acute Lymphoblastic Leukemia;Cureus;2024-06-05

3. Bayesian Modelling of Response to Therapy and Drug-Sensitivity in Acute Lymphoblastic Leukemia;Statistics in Biosciences;2024-05-29

4. Chimeric antigen receptor T-cell therapy for T-cell acute lymphoblastic leukemia;Haematologica;2024-05-10

5. Double-responsive platinum nanoclusters combined with CXCR4 antagonists and PD-L1 inhibitors for multimodal synergistic treatment of acute myeloid leukemia;2024-04-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3